Month: February 2024

Kyivstar teamKyivstar team and Mike PompeoVEON KyivstarVEON and Kyivstar LogosKyiv, 5 February 2024 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that a high-level delegation including the former U.S. Secretary of State and Kyivstar Supervisory Board member Michael R. Pompeo have recently visited the Kyivstar team in Kyiv, Ukraine.  Mike Pompeo joined the Board of Kyivstar, VEON’s wholly owned Ukrainian subsidiary, at the end of 2023. Last week, he visited Kyiv in person to attend the first Kyivstar Board meeting of the year, along with a larger VEON delegation. Addressing Kyivstar employees in a widely attended townhall, Secretary Pompeo and Kaan Terzioglu, VEON Group CEO and Chairman of the Kyivstar Board, reiterated...

Madrid and Bogotá, COLOMBIA, February 5th – The Spanish listed company Lleida.net (OTC.US) (ALLLN.PA) (LLN.MA) has signed a multi-year contract with the Colombian insurance company Seguros Mundial for the management of its certified electronic notifications. The technology will provide legal and evidentiary value to Seguros Mundial’s communications in the areas of claims, payments, objections, complaints, injunctions and personal accidents. Under the terms of the contract, Seguros Mundial will use Lleida.net’s certified email service for all its certified communications, including interactions with customers and counterparties. The contract, which covers the management of more than 70,000 monthly communications, is automatically renewed annually. Seguros Mundial, one of the leading insurers in Colombia, was founded in...

Press releaseParis, 5 February 2024 Societe Generale has announced a plan to implement organisational changes in its head office in France to simplify its operations and structurally improve its operational efficiency. During the presentation of the Group’s strategic roadmap in September 2023, Societe Generale announced a goal of gradually and significantly improving its cost/income ratio, with the achievement of approximately €1.7 billion in gross savings in 2026 compared with 2022. This amount includes synergies expected from initiatives already underway such as the creation of the new retail bank in France, the digitalisation of activities at Komerczni Banka or the integration of LeasePlan into Ayvens. It also includes additional savings of around €700 million from new projects launched in all Group entities to streamline information...

Wide Formation Mineralisation Confirmed Over a 1.6km Strike LengthNew Great Flat Lode Splay DiscoveredMultiple New Mineralised Structures Intersected Between the Great Flat Lode and Wide Formation VANCOUVER, British Columbia, Feb. 05, 2024 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing the South Crofty tin project (“South Crofty” or the “Project”) located in Cornwall, United Kingdom, to a construction decision, is pleased to report results from the first six drill holes of the ongoing 9,000 metre Carn Brea drill programme. All six drillholes intersected the Wide Formation lode structure, which is characterised by strong tourmaline alteration and variable tin mineralisation, similar to all historically mined tin-bearing...

Company announcement no. 8 / 2024Schindellegi, Switzerland – 5 February 2024 Trifork Holding AG – Weekly report on share buyback On 2 November 2023, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 2 November 2023 up to and including no later than 31 March 2024. For details, please see announcement no. 17 of 31 October 2023. Under the share buyback program, Trifork will purchase shares for up to a total of DKK 15 million (approximately EUR 2 million). Prior to the launch of the share buyback, Trifork held 232,497 treasury shares, corresponding to 1.2% of the share capital. Under the program, the following transactions have been...

5 February 2024: Borregaard ASA (“Borregaard”, OSE ticker: BRG) Borregaard employees have been given the opportunity to buy shares at a discounted price. The offer is valid from 5 February up to and including 9 February 2024. The price per share will be equal to the average volume weighted market price on 9 February 2024, with a 25% discount. Under the programme, employees may buy shares for a total amount of either NOK 5 000, NOK 15 000, NOK 25 000, NOK 40 000, NOK 55 000, or NOK 70 000. Contact:Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909  

ING to propose Deloitte as new external auditor ING will propose to the 2024 Annual General Meeting of Shareholders to appoint Deloitte Accountants BV as its next external auditor for a term of four years starting on 1 January 2026. The AGM will take place on 22 April 2024. Under European and Dutch legislation, ING is required to change its auditor at regular intervals. The nomination of Deloitte is the result of a thorough tender process overseen by the Audit Committee of the Supervisory Board and in accordance with the ING Group Policy on Auditors Independence. The audit of the 2023, 2024 and 2025 annual accounts will still be performed by KPMG Accountants NV, who have been ING’s auditor since January 2016 and will have reached the legally set maximum duration of 10 years at the end of 2025. Note for editors For further information...

Saint-Herblain (France), February 5, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it sold the Priority Review Voucher (PRV) it received from the U.S. Food and Drug Administration (FDA) for $103 million (€95 million). The Company was awarded a tropical disease PRV in November 20231 following U.S. FDA approval of IXCHIQ®, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. With this approval, IXCHIQ® became the world’s first licensed chikungunya vaccine available to address this unmet medical need. Valneva will invest proceeds from the sale of the PRV into its R&D projects, including the co-development of its Phase 3 vaccine...